EXIST Forschungstransfer Phase I vs Phase II: what each phase funds and how to plan the bridge

The most common misunderstanding is treating EXIST Forschungstransfer as a heavier version of the EXIST Gründerstipendium. They are different instruments for different situations. The Gründerstipendium funds individuals - a small founding team gets personal stipends for a year to turn an idea into a startup. Forschungstransfer funds the transfer of a substantial, often years-long research result out of a university into a company, and it does so in two distinct phases with a company formation in the middle. If your venture is essentially a good product idea with a loose university link, the Gründerstipendium is almost certainly the right track. Forschungstransfer is for ventures where the core asset is a research result that still needs significant development work to become a product - where the technical risk is real and the research lineage is central.

Because the two phases sit either side of company formation, Forschungstransfer is also a bigger commitment and a longer arc than the Gründerstipendium. You are not planning a one-year sprint; you are planning a multi-year transfer with a defined handover point. Teams that succeed with it plan both phases from the start, even though Phase II is applied for separately and is not guaranteed by a Phase I award.

Phase I funds a research-oriented team, typically embedded at the host university, to do the development and proof work that turns a research result into something investable. This is the phase for technical de-risking: building a robust prototype, validating the core scientific claim at a relevant scale, clarifying the IP situation, and testing the first market assumptions. Crucially, in Phase I there is usually no company yet - the work happens under the university's roof, with the team funded to mature the technology and prepare the spin-off. The deliverable of Phase I is a venture that is ready to incorporate: a proven core, a clear IP path, a credible business case, and a team that has decided to start the company.

Write the Phase I application around the research-to-product gap. Reviewers want to see what scientific result you are building on, who owns it, what specifically is unproven about turning it into a product, and how your phase plan closes that gap. The closer your team sits to the original research - ideally including the researchers who produced it - the stronger the application, because Forschungstransfer is fundamentally a transfer-of-people-and-knowledge instrument, not just a transfer-of-IP one.

Phase II picks up after the company is incorporated. Where Phase I de-risked the research inside the university, Phase II funds the young company to take the de-risked technology toward the market: further development, building out the team, the first commercial steps. The funding shape changes accordingly - Phase II supports the company and its activities rather than a university-embedded research team. This is the phase where the venture genuinely becomes a business, and the application is judged more like a company-funding case: a credible go-to-market, a financing plan beyond the grant, and evidence the Phase I work delivered what it promised.

Two planning realities matter here. First, Phase II is applied for separately and is not automatic - a Phase I award does not guarantee Phase II funding, so the Phase I work has to actually produce the results that make a strong Phase II case. Second, the handover between phases includes the company formation itself, which carries its own legal and tax decisions (legal form, IP assignment from the university, founder shareholdings). Plan that handover early and get proper legal and tax advice for it; the formation is not a formality you can improvise between two grant phases.

Decide the track honestly before you write a word. If the core risk in your venture is execution and go-to-market, and the technology is essentially ready, the Gründerstipendium is faster and lighter and you should not over-reach into Forschungstransfer just because the budget is bigger - reviewers see straight through a thin research story dressed up for a research-transfer programme. If the core risk is genuinely scientific or technical and the asset is a real research result that needs maturing, Forschungstransfer is built for you and the Gründerstipendium would under-fund the work.

Once you have chosen, write for the phase in front of you while keeping the whole arc visible. A Phase I application that shows you have already thought about the company formation and Phase II reads as a team that understands the journey; a Phase I application that treats Phase I as the whole story reads as short-sighted. Equally, do not over-promise the company side in Phase I - the Phase I deliverable is a fundable, formable venture, not a finished business. Match the claims to the phase, and let the plan show you know which phase you are in.